Figure 1. HCV viral decline for KIR3DS1 and its ligands during the first weeks of treatment with Peg-IFN/RBV.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.